Why the study?
Does perindopril/indapamide and/or intensive glucose control reduce macrovascular and microvascular disease in high-risk individuals with Type 2 diabetes?
Does perindopril/indapamide and/or intensive glucose control reduce macrovascular and microvascular disease in high-risk individuals with Type 2 diabetes?
The ADVANCE trial successfully recruited a large, diverse cohort of high-risk patients with Type 2 diabetes to evaluate the effects of blood pressure lowering and intensive glucose control on vascular outcomes.
No takes yet. Share an insight, caveat, or question.
Enables evaluation of combined BP-lowering and glucose strategies on vascular outcomes in high-risk T2D; extends prior evidence with a large multinational cohort.
A 2005 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: